Lithuanian fighter S. Maslobojevas has been handed a 12-month suspension by the Glory organization following a positive doping test that revealed the presence of stanozolol metabolites. The doping violation was identified in a sample collected on June 14, 2025. This situation has significant implications for his recent fight history and standing in the sport, especially after he voluntarily vacated his light heavyweight title in the wake of the allegations. Meanwhile, Glory has officially declared that his title fight is now considered a no-contest.

S. Maslobojevas has been adamant in his defense, attempting to clear his name by commissioning independent tests that he claims showed no banned substances in his body. Despite his efforts, the official ruling still stands, and he faces a financial penalty whose amount has not been disclosed. The athlete's initial response to the positive test was to contest the outcome, asserting his innocence and the integrity of his training regimen.

This incident raises broader questions about doping in competitive sports, particularly in combat sports where the stakes are incredibly high. The controversy surrounding Maslobojevas serves as a reminder of the ongoing struggle between maintaining fair competition and the serious consequences athletes face when accused of doping violations. As this story unfolds, it will be important to see how both Maslobojevas and Glory navigate the public and legal ramifications of this doping issue.